Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells
暂无分享,去创建一个
Xianrang Song | Ling Wei | Chunxi Liu | R. Sun | Haiyan Liu | Li Xie
[1] Libing Song,et al. Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival , 2008, Clinical Cancer Research.
[2] Z. Su,et al. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling , 2008, Oncogene.
[3] R. Place,et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity , 2007, Oncogene.
[4] P. Fisher,et al. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc , 2006, Proceedings of the National Academy of Sciences.
[5] Xianrang Song,et al. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene , 2006, Cancer Chemotherapy and Pharmacology.
[6] P. Fisher,et al. Activation of the Nuclear Factor κB Pathway by Astrocyte Elevated Gene-1: Implications for Tumor Progression and Metastasis , 2006 .
[7] P. Fisher,et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. , 2005, Gene.
[8] E. Ruoslahti,et al. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.
[9] H. Shimada,et al. The International Neuroblastoma Pathology Classification. , 2003, Pathologica.
[10] P. Fisher,et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH , 2002, Oncogene.
[11] K K Matthay,et al. The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.
[12] R. Castleberry. Predicting outcome in neuroblastoma. , 1999, The New England journal of medicine.
[13] S. Navarro,et al. Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting. , 1999, European journal of cancer.
[14] B. Gallie,et al. MYCN protein expression as a predictor of neuroblastoma prognosis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] F. Berthold,et al. The international neuroblastoma risk groups (INRG): a preliminary report , 1997 .
[16] P. Fisher,et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. , 2006, Cancer research.
[17] A. Craft,et al. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. , 1992, European journal of cancer.